Matsuoka, H., Makimura, C., Koyama, A., Fujita, Y., Tsurutani, J., Sakai, K., . . . Nakagawa, K. (2017). Prospective replication study implicates the catechol-O-methyltransferase Val(158)Met polymorphism as a biomarker for the response to morphine in patients with cancer. Biomed Rep.

Matsuoka, Hiromichi, Chihiro Makimura, Atsuko Koyama, Yoshihiko Fujita, Junji Tsurutani, Kiyohiro Sakai, Ryo Sakamoto, Kazuto Nishio, und Kazuhiko Nakagawa. "Prospective Replication Study Implicates the Catechol-O-methyltransferase Val(158)Met Polymorphism As a Biomarker for the Response to Morphine in Patients With Cancer." Biomed Rep 2017.

Matsuoka, Hiromichi, et al. "Prospective Replication Study Implicates the Catechol-O-methyltransferase Val(158)Met Polymorphism As a Biomarker for the Response to Morphine in Patients With Cancer." Biomed Rep 2017.